Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
Holding SLRX?
Track your performance easily

Salarius Pharmaceuticals (SLRX) Financial Statements

491 Followers

Salarius Pharmaceuticals Financial Overview

Salarius Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-12.64; its P/E ratio is -0.13; Salarius Pharmaceuticals is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.42M$ -1.72M$ -881.80K$ -2.44M$ -3.88M
EBITDA$ -1.42M$ -1.71M$ -880.69K$ -2.44M$ -3.88M
Net Income Common Stockholders$ -1.42M$ -1.72M$ -881.80K$ -2.44M$ -3.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.27M$ 4.37M$ 5.90M$ 7.58M$ 11.54M
Total Assets$ 3.55M$ 4.88M$ 6.59M$ 8.40M$ 12.03M
Total Debt$ 0.00$ 100.00K$ 300.00K$ 500.00K$ 0.00
Net Debt$ -3.27M$ -4.27M$ -5.60M$ -7.08M$ -11.54M
Total Liabilities$ 1.18M$ 1.23M$ 1.30M$ 2.32M$ 3.64M
Stockholders Equity$ 2.38M$ 3.65M$ 5.29M$ 6.08M$ 8.41M
Cash Flow-
Free Cash Flow$ -1.07M$ -1.35M$ -1.51M$ -3.75M$ -4.42M
Operating Cash Flow$ -1.07M$ -1.35M$ -1.51M$ -3.75M$ -4.42M
Investing Cash Flow-----
Financing Cash Flow$ -28.19K$ -172.75K$ -169.45K$ -211.83K$ 6.68M
Currency in USD

Salarius Pharmaceuticals Earnings and Revenue History

Salarius Pharmaceuticals Debt to Assets

Salarius Pharmaceuticals Cash Flow

Salarius Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis